Business Daily Media

Men's Weekly

.

The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward

HONG KONG SAR - Media OutReach Newswire - 2 October 2024 - The Hong Kong stock market's pharmaceutical sector has seen a strong rebound recently.
Among them, AIM Vaccine Co., Ltd. (06660.HK) led the rise in the biopharmaceutical sector. Its stock price doubled in the previous five trading days, closing at HK$8.93 on September 30, an increase of 56.12%.

At present, the Hong Kong stock market's pharmaceutical sector has entered a technical bull market, and high-quality growth stocks that were mistakenly underestimated in the early stage are experiencing a return in value. As a leading vaccine company in the industry, according to the company's 2024 Interim Report, AIM Vaccine has 3 heavyweight iterative single-product vaccines are planning to complete the application for marketing in this year, including iterative serum-free rabies vaccine, 13-valent pneumonia conjugate vaccine, and 23-valent pneumonia polysaccharide vaccine. In addition, 7 heavyweight single-product vaccines, including mRNA RSV vaccine (respiratory syncytial virus vaccine) and mRNA shingles/herpes zoster vaccine, have completed the pre-applications for clinical trials, and a series of internationalized business promotions are accelerating implementation.

In the China domestic market, the rabies vaccine market is expected to grow to RMB 22 billion by 2030, mainly due to the potential release of high-end wild vaccine products. It is understood that the iterative serum-free rabies vaccine of AIM Vaccine is completely different from the existing Vero cell rabies vaccine containing serum and human diploid rabies vaccine containing serum, the iterative serum-free rabies vaccine is an iterative product. No serum-free rabies vaccine has been approved for marketing in the global market. The iterative serum-free rabies vaccine of AIM Vaccine has completed the pre-testing for drug registration and is expected to fill the market gap after listing.

The 13-valent pneumonia conjugate vaccine (PCV13) is known as the "king of vaccines". Due to the rapid growth of PCV13, China's pneumococcal vaccine market has grown to RMB 10.75 billion in 2022 and is expected to maintain steady growth at a compound annual growth rate of 22.7%. By 2025, China's pneumococcal vaccine market will reach RMB 24 billion.

The 13-valent pneumonia conjugate vaccine of AIM Vaccine has submitted the pre-application for marketing and is accelerating the work of marketing registration. In addition, the 23-valent pneumonia polysaccharide vaccine has also completed Phase III clinical trial and will soon be unblinded for statistical analysis.

There are also many heavyweight innovative products in the AIM Vaccine R&D pipeline. Among them, the quadrivalent influenza virus vaccine (MDCK Cells) and adsorbed tetanus vaccine have officially submitted clinical trial applications; the iterative 20-valent pneumonia conjugate vaccine has completed clinical pre-application; the tetravalent meningococcal conjugate vaccine and the bivalent HFMD vaccine are accelerating clinical trials; the innovative vaccines mRNA RSV vaccine (respiratory syncytial virus vaccine) and mRNA shingles/herpes zoster vaccine have achieved dual reporting in China and the United States, aiming at the international market.

In the current strong rebound of the pharmaceutical sector, the pipeline covers the world's top ten vaccine varieties, three large single products are coming to market, and several heavyweight innovation large single vaccines have been commercialized in the next 2 to 3 years, which will contribute a steady stream of incremental performance for AIM vaccines and promote the company's high growth expectations.


Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

CTF Life Harnesses the CTF Group Ecosystem to Forge Strategic Alliances with Three Major Hospitals Enhances Hospital and PrimeChamp Doctor Network to Empower Customers with Greater Autonomy, Convenience and Comprehensive Medical Services

HONG KONG SAR - Media OutReach Newswire - 27 October 2025 - CTF Life today announced the signing of a Memorandum of Understanding with Gleneagles Hospital Hong Kong ("Gleneagles"), CUHK Medical Ce...

After five years, VinFuture stands as a symbol of confidence in science for humanity

HANOI, VIETNAM - Media OutReach Newswire - 27 October 2025 - Professor Sir Richard Henry Friend, Chair of the VinFuture Prize Council, shared that what began as a bold idea five years ago has grow...

KPMG Successfully Hosts the Inaugural Future Entrepreneur Award Ceremony to Support High-Quality Development of the Private Sector

HONG KONG SAR - Media OutReach Newswire - 27 October 2025 - Currently, with continuous innovation momentum being released, emerging industries, the digital economy, and green development are bri...

Shanghai Commercial Bank Unveils "From Shanghai to Hong Kong, Connecting the World" Exhibition To Mark Its 75th Anniversary

HONG KONG SAR - Media OutReach Newswire - 27 October 2025 - Shanghai Commercial Bank (the Bank) is pleased to celebrate its 75th anniversary with a series of events starting with a landmark exhibi...

SNP Opens New Asia-Pacific Headquarters in Singapore to Power Data Transformation and Accelerate Regional Growth

SNP has opened its new Asia-Pacific headquarters in Singapore, strengthening its presence and commitment to the region. The company delivered more than 50 successful go-lives in A...

Wildberries E-Commerce Platform Opens Its Highest-Altitude Order Pickup Point

KHOROG, TAJIKISTAN - Media OutReach Newswire - 28 October 2025 - Wildberries, a leading digital platform Eurasia, has opened its highest-altitude pickup point for online orders placed on its marke...

Chinese Spirulina Industry Expands Global Reach, Promoting Health and Nutrition Benefits

ORDOS, CHINA - Media OutReach Newswire - 27 October 2025 - On September 27, a batch of spirulina products from Otog Banner in Ordos City, Inner Mongolia, set sail from Tianjin Port to Los Angeles...

FBS and Bros Gang TV Bring Meaningful Change to Malaysia’s Orang Asli Community

SINGAPORE - Media OutReach Newswire - 28 October 2025 - FBS, a leading global broker, partnered with Malaysian content creator Bros Gang TV to support the Orang Asli community in Taman Negara Pah...

MIPIM Asia 2025 Awards Finalists Revealed

30 finalists emerge from a competitive field of entries spanning 10 prestigious categories set to be unveiled at MIPIM Asia Gala Dinner HONG KONG SAR - Media OutReach Newswire - 28 October 2025 - ...

Amazon Singapore Shares the Joy with 12 Days of Black Friday Deals and New Shopper Insights

Hundreds of thousands of deals from top local and international brands including Dyson, LEGO, Sennheiser and Beauty of Joseon, across Amazon.sg – the perfect way to start the holidays early...

The Future of Wealth Technology

“You shouldn’t need a large account balance to experience real-time investing. Technology should make that kind of access universal.” For decades...

Thryv wins national accolade at 2025 Australian Service Excellence Awards

  Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, announced that Greg Nicolle, G...

pay.com.au unveils first-of-its-kind FX rewards feature, becoming the most flexible rewards solution for Aussie businesses

pay.com.au, the end-to-end payments and rewards platform, today announced the launch of International Payments, Australia’s first foreign exchange...

Yellow Canary partners with Celery to bring pre-payroll assurance technology to Australia

Wage underpayment headlines continue to put pressure on employers of all sizes, revealing how costly payroll mistakes can be for small and medium bu...

Brennan Bolsters Leadership to Accelerate Next Growth Chapter

In a move to further embed cybersecurity at the heart of its business strategy and deliver sovereign secure-by-design solutions for its customers, A...

How to Be Investable: Insights from Richelle Nicols, CEO of Pollinatr

Richelle Nicols is the CEO of Pollinatr, a pioneering investment and business development program designed to support and accelerate the growth of s...